Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections

Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections

Three years after its first discovery in Jeddah Saudi Arabia, the novel zoonotic pathogen of humans, the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) continues to be a major threat to global health security.1 Sporadic community acquired cases of MERS continue to be reported from the Middl...

Full description

Bibliographic Details
Main Authors: Alimuddin Zumla, Esam I. Azhar, Yaseen Arabi, Badriah Alotaibi, Martin Rao, Brian McCloskey, Eskild Petersen, Markus Maeurer
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971215002155

Internet

http://www.sciencedirect.com/science/article/pii/S1201971215002155

Similar Items